These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22378555)

  • 1. In vitro CMV-infection model in fresh and glycerolized skin graft.
    Astegiano S; Alotto D; Castagnoli C; Sinesi F; Stella M; Bergallo M; Cavallo R
    New Microbiol; 2012 Jan; 35(1):67-71. PubMed ID: 22378555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus load in fresh and glycerolized skin grafts.
    Astegiano S; Sidoti F; Costa C; Ostorero A; Alotto D; Castagnoli C; Bergallo M; Stella M; Cavallo R
    New Microbiol; 2010 Jul; 33(3):253-6. PubMed ID: 20954444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].
    Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E
    Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of donor-recipient cytomegalovirus serology on adult liver transplantation: a single center experience.
    Tryphonopoulos P; Weppler D; Morris MI; Russo C; Nishida S; Levi DM; Moon J; Tekin A; Selvaggi G; Island E; Arosemena L; Ruiz P; Tzakis AG
    Transplantation; 2011 Nov; 92(9):1051-7. PubMed ID: 21876474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay.
    Gouarin S; Vabret A; Scieux C; Agbalika F; Cherot J; Mengelle C; Deback C; Petitjean J; Dina J; Freymuth F
    J Virol Methods; 2007 Dec; 146(1-2):147-54. PubMed ID: 17673304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agents.
    Jayarama V; Marcello J; Ohagen A; Gibaja V; Lunderville D; Horrigan J; Chapman J; Lazo A
    Transfusion; 2006 Sep; 46(9):1580-8. PubMed ID: 16965587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant.
    Hebart H; Wuchter P; Loeffler J; Gscheidle B; Hamprecht K; Sinzger C; Jahn G; Dietz K; Kanz L; Einsele H
    Bone Marrow Transplant; 2001 Jul; 28(2):213-8. PubMed ID: 11509941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
    Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
    Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
    Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
    J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.
    Christmas SE; Halliday D; Lawton N; Wang H; Abdalla I; Masters J; Hassan RL; Hart IJ; Khan N; Smith J; Hammad A; Bakran A
    Transpl Immunol; 2009 Dec; 22(1-2):99-104. PubMed ID: 19635559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of real-time polymerase chain reaction and antigenemia assay to detect cytomegalovirus in pediatric transplants].
    Farfán U MJ; Torres T JP; Vergara A A; Donoso W G; Alba G A; Paris D C; Santolaya De P ME
    Rev Chilena Infectol; 2011 Apr; 28(2):113-7. PubMed ID: 21720689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadaver skin allografts and transmission of human cytomegalovirus to burn patients.
    Kealey GP; Aguiar J; Lewis RW; Rosenquist MD; Strauss RG; Bale JF
    J Am Coll Surg; 1996 Mar; 182(3):201-5. PubMed ID: 8603237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid diagnosis of cytomegalovirus lung infection by DNA amplification in bronchoalveolar lavages.
    Liesnard C; De Wit L; Motte S; Brancart F; Content J
    Mol Cell Probes; 1994 Aug; 8(4):273-83. PubMed ID: 7870069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human fibroblasts are permissive for porcine cytomegalovirus in vitro.
    Whitteker JL; Dudani AK; Tackaberry ES
    Transplantation; 2008 Jul; 86(1):155-62. PubMed ID: 18622293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.